Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Unknown 3

Sponsor Class

OTHER 814NETWORK 26INDUSTRY 23NIH 20OTHER_GOV 8UNKNOWN 3FED 2

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 2Thoracic 1

Conditions

Colorectal Neoplasms 2Carcinoma, Non-Small-Cell Lung 1

Interventions

Paclitaxel 20Capecitabine 18S 1 (combination) 17Cisplatin 15Oxaliplatin 11Radiotherapy, Intensity-Modulated 9apatinib 8Epirubicin 8Docetaxel 8Carboplatin 8Radiotherapy 7Irinotecan 7titanium silicide 6sintilimab 6pyrotinib 6nimotuzumab 6anlotinib 6Drug Therapy 6Albumin-Bound Paclitaxel 6130-nm albumin-bound paclitaxel 6nedaplatin 5camrelizumab 5Temozolomide 5Etoposide 5Bevacizumab 5nabiximols 4Vinorelbine 4Trastuzumab 4Radiation Dose Hypofractionation 4Radiation 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
UNKNOWN × Radiosurgery × Clear all
NCT03927898 2019-04-25

Phase II Study of Toripalimab Plus Stereotactic Body Radiotherapy in Colorectal Cancer Patients With Oligometastasis

ChineseAMS

Phase 2 Unknown
40 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT02909114 2016-09-21

Stereotactic Body Radiotherapy for Oligometastases From Colorectal Cancer

ChineseAMS

Phase 2 Unknown
50 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT02584699 2015-10-23

Study of Stereotactic Ablative Radiotherapy (SABR) in Elderly Stage I NSCLC

ChineseAMS

Phase 2 Unknown
40 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡